Here’s What We’re Presenting This Month at WODC 2020
The World Orphan Drug Congress is going virtual this year, and Premier Research has two presentations packed with real-world insights that you won’t want to miss. Here are two big reasons to save the date for August 24-27 this year:
- Rare Disease Recruitment: Addressing Enrollment Hurdles and Differentiating Your Clinical Trial in an Increasingly Competitive Research Environment
Aug. 25, 1:10-1:30 PM EDT
Jonathan Kornstein, Executive Director, Program Strategy, Rare Disease & Pediatrics, will discuss current obstacles and unique solutions to bolster enrollment in rare disease research.
- A New Era of Clinical Trials Informed by Patient-Focused Clinical Reported Outcome Measures and Real World Evidence
Aug. 25, 4:20-5:10 PM EDT
Nach Davé, Vice President, Development Strategy, will moderate a panel discussion exploring the expanding role of patient-focused outcome measures and real-world evidence in clinical research.
Rare Disease Study Insights From Premier Research
Rare Disease Clinical Trial Experience
Real-World Data and Real-World Evidence: What Is Their Value as a Synthetic Control Arm?
Mapping the New Landscape of Orphan Drug Development